Document is current
Any future updates will be listed below
-
Authors
Hunjan, Manjit
Curran, Desmond https://orcid.org/0000-0002-7423-0111
Marijam, Alen
Vekria, Yasmeeta
Giannelos, Nikolaos
-
Funding
Funding for this research was provided by:
GlaxoSmithKline Biologicals SA
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 30 October 2024
First Online: 26 November 2024
Declarations
:
: Desmond Curran, Alen Marijam, Yasmeeta Vekria and Nikolaos Giannelos are GSK employees. Manjit Hunjan was a GSK employee at the time of the study. Manjit Hunjan, Desmond Curran, Alen Marijam, Yasmeeta Vekria and Nikolaos Giannelos hold financial equities in GSK. Manjit Hunjan and Yasmeeta Vekria are share-holders in Haleon. All authors declare no other financial and non-financial relationships and activities.
: As this was a modelling study, no ethics committee approval was required.
: Shingrix is a trademark owned by or licensed to GSK. AS01 is a trademark owned by or licensed to GSK. Zostavax is a trademark of MSD.
